Leading the way to safer medication
 Crosscheck  Recommender


Therapeutic Indications

Aminophylline is indicated for:

Pulmonary oedema, paroxysmal nocturnal dyspnoea, status asthmaticus, acute bronchospasm

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Aminophylline is indicated for diseases of the cardiovascular system (e.g. an adjunct in the treatment of pulmonary oedema or paroxysmal nocturnal dyspnoea caused by left ventricular heart failure), reversible airways obstruction including status asthmaticus and acute bronchospasm.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 5-7mg/kg daily


Active ingredient Aminophylline is contraindicated in the following cases:

Xanthine derivatives

No gender/age discrimination

Concurrent use of other xanthine derivatives, including theophylline and pentoxifylline are contraindicated due to the risk of toxicity.

Acute porphyria

No gender/age discrimination

The use of aminophylline is contraindicated in patients with acute porphyria.